Hepar sulfuris Sinus (Uriel Pharmacy Inc.)


Welcome to the PulseAid listing for the Hepar sulfuris Sinus drug offered from Uriel Pharmacy Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Uriel Pharmacy Inc.
NON-PROPRIETARY NAME: Hepar sulfuris Sinus
SUBSTANCE NAME: CALCIUM SULFIDE; BOS TAURUS NASAL MUCOSA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00


Hepar sulfuris Sinus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHepar sulfuris Sinus from Uriel Pharmacy Inc.
LABELER NAME: Uriel Pharmacy Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 8([hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 48951-5049_024e7c4a-1fca-4235-bd95-0702f34bf537
PRODUCT NDC: 48951-5049
APPLICATION NUMBER:

Other CALCIUM SULFIDE; BOS TAURUS NASAL MUCOSA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Uriel Pharmacy Inc.Hepar sulfuris Sinus